BioAtla (BCAB) Change in Cash (2020 - 2026)

BioAtla (BCAB) has reported Change in Cash for 7 consecutive years, with -$417000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash rose 97.05% year-over-year to -$417000.0; the trailing twelve-month figure through Jun 2026 stood at -$16.7 million (up 61.65% YoY), and the FY2025 full-year result was -$41.9 million, up 32.83% from the prior year.
• Change in Cash grew to -$417000.0 in Q2 2026 per BCAB's latest filing, from -$5.2 million in the prior quarter.
• Across five years, Change in Cash topped out at $37.4 million in Q4 2022 and bottomed at -$30.8 million in Q1 2024.
• Historically, Change in Cash has averaged -$13.5 million across 5 years, with a median of -$16.9 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Change in Cash jumped 249.87% in 2022, then tumbled 179.74% in 2023.
• Over 5 years, Change in Cash stood at $37.4 million in 2022, then sank by 179.74% to -$29.8 million in 2023, then surged by 74.94% to -$7.5 million in 2024, then jumped by 83.91% to -$1.2 million in 2025, then jumped by 65.31% to -$417000.0 in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$417000.0, -$5.2 million, and -$1.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.